Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Polynovo (CALZF) vs. Competitors

22 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CALZFPolynovo $0.53$381.93M76.42-28.28%Strong BuyUnlock the CALZF analyst price target with TipRanks PremiumCALZFUnlock the CALZF top-analyst price target with TipRanks Premium
AU:EYENova Eye MedicalAUD 0.16AUD 45.59M-10.2019.23%―Unlock the AU:EYE analyst price target with TipRanks PremiumCALZF vs AU:EYEUnlock the AU:EYE top-analyst price target with TipRanks Premium
AU:COHCochlear AUD 149.99AUD 10.06B66.66-44.33%HoldUnlock the AU:COH analyst price target with TipRanks PremiumCALZF vs AU:COHUnlock the AU:COH top-analyst price target with TipRanks Premium
AU:MX1Micro-X Ltd.AUD 0.03AUD 21.83M-2.03-67.42%HoldUnlock the AU:MX1 analyst price target with TipRanks PremiumCALZF vs AU:MX1Unlock the AU:MX1 top-analyst price target with TipRanks Premium
AU:ARXAroa Biosurgery LtdAUD 0.49AUD 169.29M40.42-26.52%Moderate BuyUnlock the AU:ARX analyst price target with TipRanks PremiumCALZF vs AU:ARXUnlock the AU:ARX top-analyst price target with TipRanks Premium
AU:EBREBR Systems, Inc. Shs Chess Depository Interests Repr 1 ShAUD 0.16AUD 131.05M-1.16-84.31%Moderate BuyUnlock the AU:EBR analyst price target with TipRanks PremiumCALZF vs AU:EBRUnlock the AU:EBR top-analyst price target with TipRanks Premium

Performance Comparison

-100%-75%-50%-25%0%25%50%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CALZFPolynovo 0.53-0.21-28.86%
AU:EYENova Eye Medical0.150.0219.23%
AU:COHCochlear 149.99-111.17-42.57%
AU:MX1Micro-X Ltd.0.03-0.05-63.75%
AU:ARXAroa Biosurgery Ltd0.48-0.19-27.61%
AU:EBREBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh0.16-0.82-83.71%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts